` 000028 (China National Accord Medicines Corp Ltd) vs Shanghai Composite Comparison - Alpha Spread

000028
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of -8% compared to the Shanghai Composite's 10% growth.

Stocks Performance
000028 vs Shanghai Composite

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
000028 vs Shanghai Composite

Loading
000028
Shanghai Composite
Difference

Performance By Year
000028 vs Shanghai Composite

Loading
000028
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
China National Accord Medicines Corp Ltd vs Peers

Shanghai Composite
000028
MCK
COR
0HF3
CAH
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

China National Accord Medicines Corp Ltd
Glance View

Market Cap
12.7B CNY
Industry
Health Care

China National Accord Medicines Corp Ltd, nestled within the bustling healthcare landscape of China, operates at the heart of the pharmaceutical distribution and retail sectors. Established with the goal of ensuring that essential medicines and healthcare services are accessible to the vast Chinese population, the company has built an extensive distribution network. This network efficiently links manufacturers with hospitals, clinics, and pharmacies, making certain that a myriad of pharmaceutical products reach their intended destinations. By leveraging a combination of logistical prowess and vast geographical coverage, the company adeptly navigates the complexities of supply chain management, underscoring its role as a critical player in China's healthcare infrastructure. Beyond distribution, China National Accord Medicines also capitalizes on the booming retail pharmaceuticals market through its chain of pharmacies. These retail outlets serve as direct points of sale to consumers, offering both prescription and over-the-counter medications, alongside health consultation services. This dual focus on both wholesale distribution and retail outlets enables the company to capture value across the supply chain, from manufacturer to end-user. The strategic alignment of its operations streamlines efficiency and generates revenue, sustaining its growth amid a fiercely competitive and rapidly evolving market. Through this integrated approach, the company solidifies its position as a crucial conduit in the delivery of healthcare solutions across China.

Intrinsic Value
81 CNY
Undervaluation 68%
Intrinsic Value
Price
C
Back to Top